Carrier-mediated serotonin release induced by d-fenfluramine: Studies with human neuroblastoma cells transfected with a rat serotonin transporter

Neuropharmacology

Volumn 36, Issue 6, 1997, Pages 803-809

  Cinquanta, M ^a   Ratovitski, T ^b   Crespi, D ^a   Gobbi, M ^a   Mennini, T ^a   Simantov, R ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

d fenfluramine; Serotonin release; Serotonin transporter; Transfected human neuroblastoma cells

Indexed keywords

CITALOPRAM; DEXFENFLURAMINE;

ARTICLE; HUMAN; HUMAN CELL; OBESITY; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE; SYNAPTOSOME;

ANIMALS; CALCIUM; CARRIER PROTEINS; CITALOPRAM; FENFLURAMINE; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NEUROBLASTOMA; POTASSIUM; RATS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030838533     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00064-6     Document Type: Article

References (32)

1. Blakely R., Berson H., Fremeau R., Caron M., Peek M., Prince H. and Bradely C. (1991) Cloning and expression of a functional serotonin transporter from rat brain. Nature 354: 66-70.
2. Bonanno G., Fassio A., Severi P., Ruelle A. and Raiteri M. (1994) Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism. Journal of Neurochemistry 63: 1163-1166.
3. Brodeur G. M., Sekkon G. S. and Goldstein M. M. (1977) Chromosomal abberrations in human neuroblastoma. Cancer 40: 2256-2763.
4. Caccia S., Anelli M., Fracasso C., Frittoli E., Giorcelli P., Gobbi M., Taddei C., Garattini S. and Mennini T. (1993) Anorectic effect and brain concentrations of d-fenfluramine in the marmoset: relationship to the in vivo and in vitro effects on serotonergic mechanisms. Naunyn-Schmiedeberg's Archives of Pharmacology 347: 306-312.
5. 3H]5-HT release from ret hippocampal synaptosomes. Neuropharmacology 33: 833-835.
6. Garattini S., Bizzi A., Caccia S. and Mennini T. (1992) Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline. International Journal of Obesity 16 (Suppl. 3): S43-S50.
7. Garattini S., Mennini T., Bendotti C., Invernizzi R. and Samanin R. (1986) Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system. Appetite 7 (Suppl.): 15-38.
8. Garattini, S., Mennini, T. and Samanin, R. (1989) Central serotonergic mechanisms and feeding regulation. In: Neuro-chemical Pharmacology. A Tribute to B. B. Brodie (Costa E., Ed.), pp. 89-106, Raven Press, New York.
9. Gobbi M., Frittoli E., Mennini T. and Garattini S. (1992) Releasing activities of d-fenfluramine and fluoxetine on rat hippocampal synaptosomes preloaded with [3H]serotonin. Naunyn-Schmiedeberg 's Archives of Pharmacology 345: 1-6.
10. Gobbi M., Frittoli E., Uslenghi A. and Mennini T. (1993) Evidence of an exocytotic-like release of [3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes. European Journal of Pharmacology 238: 9-17.
11. Hoffman B. J., Mezey E. and Brownstein M. J. (1991) Cloning of a serotonin transporter affected by antidepressants. Science 254: 579-580.
12. Levi G. and Raiteri M. (1974) Exchange of neurotransmitter amino acid at nerve endings can simulate high affinity uptake. Nature 250: 735-737.
13. Levi G. and Raiteri M. (1978) Modulation of gamma-aminobutyric acid transport in nerve endings: role of extracellular gamma-aminobutyric acid and cationic fluxes. Proceedings of the National Academy of Science U.S.A. 75: 2981-2985.
14. Levi G. and Raiteri M. (1993) Carrier-mediated release of neurotransmitters. Trends in Neurological Science 16: 415-419.
15. Levi G., Coletti A., Poce U. and Raiteri M. (1976) Decrease of uptake and exchange of neurotransmitter amino acids after depletion of their synaptosomal pools. Brain Research 103: 103-116.
16. Lowry O. H., Rosenbrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193: 265-275.
17. Maura G., Gemignani A., Versace P., Martire M. and Raiteri M. (1982) Carrier-mediated and carrier-independent release of serotonin from isolated central nerve endings. Neurochemistry International 4: 219-224.
18. Mennini T., Bizzi A., Caccia S., Codegoni A., Fracasso C., Frittoli E., Guiso G., Martin Padura I., Taddei C., Uslenghi A. and Garattini S. (1991) Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs. Naunyn-Schmiedeberg's Archives of Pharmacology 343: 483-490.
19. Mennini T., Borroni E., Samanin R. and Garattini S. (1981) Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotonin. Neurochemistry International 3: 289-294.
20. Mennini T., Fracasso C., Cagnotto A., Bergami A., Frittoli E., Gobbi M., Caccia S. and Garattini S. (1996) In vitro and in vivo effects of the anorectic agent dexfenfluramine on non-human primate serotonergic system. Naunyn-Schmiedeberg's Archives of Pharmacology 353: 641-647.
21. Mennini T., Garattini S. and Caccia S. (1985) Anorectic effect of fenfluramine isomers and metabolites: Relationship between brain levels and in vitro potencies on serotonergic mechanisms. Psychopharmacology 85: 111-114.
22. Nelson P. J. and Rudnick G. (1979) Coupling between platelet 5-hydroxytryptamine and potassium transport. Journal of Biological Chemistry 254: 10084-10089.
23. Ratovitski T., Tauber, M., Tafet, G. and Simantov, R. (1996) Regulation of serotonin transporters by protein kinases, studies with transfected cells. Pharmacology Research Communications, in press.
24. 3H-norepinephrine induced by various agents in hypothalamic synaptosomes. Molecular Pharmacology 13: 746-758.
25. Raiteri M., Cerrito F., Cervoni A. M. and Levi G. (1979) Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. Journal of Pharmacology and Experimental Therapeutics 208: 195-202.
26. Rudnick G. and Wall S. C. (1992a) The molecular mechanism of "ecstasy" [3,4-methylenedyoxymethamphetamine(MDMA)]: Serotonin transporters are targets for MDMA-induced serotonin release. Proceedings of the National Academy of Science U.S.A. 89: 1817-1821.
27. Rudnick G. and Wall S. C. (1992b) p-Chloroamphetamine induces serotonin release through serotonin transporters. Biochemistry 31: 6710-6718.
28. Schuldiner S., Steiner-Mordoch S., Yelin R., Wall S. C. and Rudnick G. (1993) Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters. Molecular Pharmacology 44: 1227-1231.
29. Simantov, R., Blinder, H., Ratoviski, T., Tauber, M., Porat, S. and Gabbay, M. (1996) Dopamine-induced apoptosis in human neuronal cells: Inhibition by nucleic acids antisense to dopamine transporter. Neuroscience 74: 39-50.
30. Smith J. A. M., Loughlin S. E. and Leslie F. M. (1992) k-opioid inhibition of [3H]dopamine release from rat ventral mesencephalic dissociated cell cultures. Molecular Pharmacology 42: 575-583.
31. Vree T. B., Muskens A. Th. J. M. and Rossum J. M van (1969) Some psycochemical properties of amphetamine and related compounds. Journal of Pharmacy and Pharmacology 21: 774-775.
32. Wall S. C., Gu H. and Rudnick G. (1995) Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Molecular Pharmacology 47: 544-550.